Cargando…
Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
Autores principales: | Efe, Orhan, Goyal, Lipika, Galway, Aralee, Zhu, Andrew X., Niles, John L., Zonozi, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116759/ https://www.ncbi.nlm.nih.gov/pubmed/34013127 http://dx.doi.org/10.1016/j.ekir.2021.03.001 |
Ejemplares similares
-
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019) -
Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease
por: Nithagon, Pravarut, et al.
Publicado: (2021) -
The use of eculizumab in gemcitabine induced thrombotic microangiopathy
por: Krishnappa, Vinod, et al.
Publicado: (2018) -
Diagnostic Dilemma of Thrombotic Microangiopathy in Pregnancy
por: Kaartinen, Kati, et al.
Publicado: (2020) -
Gemcitabine-Induced Thrombotic Microangiopathy Managed Conservatively in a Patient of Breast Cancer
por: Ghumman, Ghulam Mujtaba, et al.
Publicado: (2022)